A detailed history of Syon Capital LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Syon Capital LLC holds 13,520 shares of EXAS stock, worth $665,995. This represents 0.07% of its overall portfolio holdings.

Number of Shares
13,520
Holding current value
$665,995
% of portfolio
0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$49.33 - $71.97 $666,941 - $973,034
13,520 New
13,520 $760 Million
Q4 2023

Feb 02, 2024

BUY
$59.06 - $75.72 $171,333 - $219,663
2,901 New
2,901 $215 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.72B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.